Skip to the page

Data / Form D filings / Medicovestor, Inc.

Medicovestor, Inc.: Form D filing

Medicovestor, Inc., a biotechnology company in New York, NY, filed a Form D with the SEC in 2025. The latest, on December 5, 2025, reports $3.2 million sold of a $4.1 million offering to 60 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
17 STATE STREET, 40TH FLOOR, New York, NY, 10004
Phone
(917) 795-8834
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2099357

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 5, 2025New notice$4,064,834$3,164,834$900,00060Nov 5, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Seah Hooi LimExecutive Officer, Director
Chit Peter Behrang LohDirector
William Peter Behrang ClementiDirector
Farrah Peter Behrang OfnerDirector
Lin Hu Hooi OngExecutive Officer, Director
Keung Wah Ken TangExecutive Officer
Benjamin Peter Behrang ValiExecutive Officer, Director

Other biotechnology companies in New York that filed recently

Every Form D from the week of Dec 1, 2025 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Medicovestor, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.